Prevention of Arrhythmia Device Infection Trial (PADIT)

PHASE4CompletedINTERVENTIONAL
Enrollment

12,814

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

September 8, 2017

Study Completion Date

September 8, 2017

Conditions
Arrhythmia
Interventions
DRUG

Incremental

Single dose of Cefazolin and Vancomycin preoperatively, bacitracin wash and cefalexin post operative.

DRUG

Conventional

Cefazolin preoperative

Trial Locations (1)

L8L 2X2

Coordinating Centre: Population Health Research Institute, Hamilton

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Population Health Research Institute

OTHER